Michael Sweeney M.D., CMO and VP, R&D at DEPOMED INC (DEPO), sold 1,418 shares at $5.77 ($8K) on 2012-12-06, disclosed to the SEC on 2012-12-06.
Scheduled sale ($8k) by CMO and VP, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DEPO | SELL | 2011-06-15 | $48K | — | Filing → |